Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 9/20 | 0.74 |
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8557860 | 0.85 | GRM5 (1.00) | GRM5NPC1RAB9A | |
| SCHEMBL9963860 | 0.83 | GRM5 (0.75) | GRM5NPC1RAB9APKM | |
| SCHEMBL9753586 | 0.83 | RAB9A (0.88) | GRM5NPC1RAB9AKMT2AATM | |
| SCHEMBL13296220 | 0.82 | GRM5 (0.82) | GRM5NPC1RAB9APKMKMT2A | |
| SCHEMBL11036192 | 0.81 | KMT2A (0.82) | GRM5NPC1RAB9AKMT2A | |
| SCHEMBL21652196 | 0.80 | GRM5 (0.70) | GRM5NPC1RAB9APKMKMT2A | |
| SCHEMBL10806526 | 0.79 | GRM5 (0.68) | GRM5NPC1RAB9APKM | |
| Glutarate SCHEMBL1649213 | 0.79 | GRM5 (0.68) | GRM5NPC1RAB9AKMT2AATM | |
| SCHEMBL23367929 | 0.78 | GRM5 (0.75) | GRM5NPC1RAB9APKMKMT2A | |
| SCHEMBL2947068 | 0.78 | GRM5 (0.68) | GRM5NPC1RAB9APKMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0815108-A1 | CYCLIC UREA HIV PROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-01-07 | — | — | EP | claimed |
| US-5683999-A | Cyclic urea HIV protease inhibitors | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-11-04 | — | — | US | claimed |
| EP-0815108-A1 | CYCLIC UREA HIV PROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| US-5683999-A | Cyclic urea HIV protease inhibitors | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-11-04 | — | — | US | disclosed |